Develops innovative logic-gated cell therapies that selectively target and eliminate solid tumor cancers while protecting normal healthy tissue.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
A2 Biotherapeutics develops innovative, logic-gated cell therapies designed to selectively target and eliminate solid tumor cancers. The biotechnology enterprise utilizes a proprietary technology platform to engineer immune cells with a dual-receptor mechanism consisting of an activator that identifies tumor cells and a blocker that protects normal tissue.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
A2 Biotherapeutics Management Team
Investors
Samsara BioCapital
A2 Biotherapeutics Valuations & Financials
View real-time NPM data on A2 Biotherapeutics stock including daily A2 Biotherapeutics stock price estimates, valuation history, and historical share price information. Access A2 Biotherapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track A2 Biotherapeutics pricing across six independent market signals. Looking for private company due diligence data sources on A2 Biotherapeutics? Get in touch to learn more.
Similar Companies
like A2 Biotherapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Lakeba
AI & Machine Learning
Global venture studio that focuses on transforming digital technologies into successful businesses
Zeel
Consumer
Delivering licensed wellness therapies that bring personalized, in-home massage sessions and recovery treatments via a seamless on-demand platform.
Loft Orbital
Industrials
Leases space on satellites for any organization to collect information about the earth.
Checkerspot
Climate & Sustainability
Develops microalgae-based materials that replace traditional inputs to create sustainable, high-performance products.
SingleFile Technologies
Enterprise Software
Automates entity compliance tasks and simplifies regulatory filings into a unified, smart workflow.
Substack
Media & Entertainment
Lets writers connect with their audience on their own terms and earn money doing it.
Starbird
Consumer
Operates automated restaurants that use robotic systems to prepare food and manage kitchen operations.
FAQ
We have answers
A2 Biotherapeutics stock does not trade on public stock exchanges. A2 Biotherapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in A2 Biotherapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
A2 Biotherapeutics Stock does not trade on public stock exchanges. In order to sell A2 Biotherapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
A2 Biotherapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view A2 Biotherapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for A2 Biotherapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell A2 Biotherapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in A2 Biotherapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
A2 Biotherapeutics is a private company and has not had an IPO. There is currently no A2 Biotherapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to A2 Biotherapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
